UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028427
Receipt number R000032534
Scientific Title Effectiveness and safety of bronchial thermoplasty-A multicenter study in Japan
Date of disclosure of the study information 2017/08/01
Last modified on 2017/07/28 15:22:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness and safety of bronchial thermoplasty-A multicenter study in Japan

Acronym

A multicenter study of bronchial thermoplasty in Japan

Scientific Title

Effectiveness and safety of bronchial thermoplasty-A multicenter study in Japan

Scientific Title:Acronym

A multicenter study of bronchial thermoplasty in Japan

Region

Japan


Condition

Condition

Severe asthma

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the effectiveness and safety of bronchial thermoplasty for severe asthma in Japanese multicenter study.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

QOL (quality of life)(at 3M,6M,and 12M)

Key secondary outcomes

Asthma exacerbation
Emergency room visits
Unscheduled physician office visits
Hospitalization frequency
Hospitalizations
Days missed from work/school
Physician's Global Evaluation of Treatment Effectiveness (GETE) assessment
Therapeutic drug use
Pulmonary function
Adverse events
(at 3M,6M,and 12M)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

bronchial thermoplasty(3 times every 3 weeks)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Uncontrolled severe asthma patients treated with high dose inhaled corticosteroid and long-acting beta2-agonists.
2. Eligible for fiberoptic bronchoscopy.

Key exclusion criteria

1. Have a pacemaker, implantable cardioverter defibrillator, or other implantable electronic device.
2. Have a known sensitivity to medications required to perform bronchoscopy, including lidocaine, atropine, and benzodiazepines.
3. Have been previously treated with BT
4. Active respiratory infection
5. Asthma exacerbation or changing dose of systemic corticosteroids for asthma in the past 14 days
6. Known coagulopathy. As with other bronchoscopic procedures, patients should stop taking anticoagulants, antiplatelet agents, aspirin, and NSAIDS before the procedure with physician guidance

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshiki Ishii

Organization

Dokkyo Medical University Hospital

Division name

Department of Pulmonary Medicine and Clinical Immunology

Zip code


Address

880 Kitakobayashi, Mibu, Tochigi, Japan

TEL

0282-87-2151

Email

ishiiysk@dfokkyomed.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Akihiro Takemasa

Organization

Dokkyo Medical University Hospital

Division name

Department of Pulmonary Medicine and Clinical Immunology

Zip code


Address

880 Kitakobayashi, Mibu, Tochigi, Japan

TEL

0282-87-2151

Homepage URL


Email

takemasa@dokkyomed.ac.jp


Sponsor or person

Institute

Japanese study group for bronchial thermoplasty(J-brothers)

Institute

Department

Personal name



Funding Source

Organization

Dokkyo Medical University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Japanese study group for bronchial thermoplasty(J-brothers)

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 07 Month 19 Day

Date of IRB


Anticipated trial start date

2017 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 07 Month 28 Day

Last modified on

2017 Year 07 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032534